Indication
Musculoskeletal pain
Musculoskeletal pain is an acute or chronic sensory symptom arising from damage, strain, inflammation, or functional impairment within the somatic structures of the locomotor system. Read more about Musculoskeletal pain
7 drugs 4 manufacturers
Drugs that treat it
Common Musculoskeletal pain therapies.
ORPHENADRINE COMPOUND-DS (orphenadrine citrate/aspirin/caffeine)
ORPHENADRINE-ASA-CAFFEINE (orphenadrine citrate/aspirin/caffeine)
NORGESIC FORTE (orphenadrine citrate/aspirin/caffeine)
ORPHENGESIC FORTE (orphenadrine citrate/aspirin/caffeine)
NORGESIC (orphenadrine citrate/aspirin/caffeine)
ORPHENADRINE-ASPIRIN-CAFFEINE (orphenadrine citrate/aspirin/caffeine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMusculoskeletal pain is an acute or chronic sensory symptom arising from damage, strain, inflammation, or functional impairment within the somatic structures of the locomotor system.
It primarily affects the bones, joints, skeletal muscles, tendons, ligaments, and adjacent connective tissues or nerves across diverse patient populations.
Pathophysiologically, it commonly involves mechanical or biochemical activation of peripheral nociceptors, localized inflammatory mediator release, and in chronic or widespread presentations, peripheral and central nervous system sensitization.
Clinically, it typically manifests as deep, aching, sharp, or throbbing discomfort that is often exacerbated by movement or weight-bearing, frequently accompanied by joint stiffness, localized tenderness, muscle spasms, and functional limitations.
- nih.gov
Musculoskeletal pain is an acute or chronic sensory symptom arising from damage, strain, inflammation, or functional impairment within the somatic structures of the locomotor system It primarily affects the bones, joints, skeletal muscles, tendons, ligaments, and adjacent connective tissues or nerves across diverse patient populations
- nih.gov
Musculoskeletal pain is an acute or chronic sensory symptom arising from damage, strain, inflammation, or functional impairment within the somatic structures of the locomotor system Pathophysiologically, it commonly involves mechanical or biochemical activation of peripheral nociceptors, localized inflammatory mediator release, and in chronic or widespread presentations, peripheral and central nervous system sensitization Clinically, it typically manifests as deep, aching, sharp, or throbbing di...
- nih.gov
It primarily affects the bones, joints, skeletal muscles, tendons, ligaments, and adjacent connective tissues or nerves across diverse patient populations Clinically, it typically manifests as deep, aching, sharp, or throbbing discomfort that is often exacerbated by movement or weight-bearing, frequently accompanied by joint stiffness, localized tenderness, muscle spasms, and functional limitations
- medlineplus.gov
Pathophysiologically, it commonly involves mechanical or biochemical activation of peripheral nociceptors, localized inflammatory mediator release, and in chronic or widespread presentations, peripheral and central nervous system sensitization
- nih.gov
Clinically, it typically manifests as deep, aching, sharp, or throbbing discomfort that is often exacerbated by movement or weight-bearing, frequently accompanied by joint stiffness, localized tenderness, muscle spasms, and functional limitations
Personalize your experience
Follow Musculoskeletal pain and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.